Immunoclassification of Psoriasis: a Strategy for Precision Medicine
Conditions: Immunoclassification; Psoriasis Intervention: Biological: adalimumab, secukinumab, ixekizumab, guselkumab, Jak inhibitors, methotrexate Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials